AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NRX Pharmaceuticals, Inc. Director's Dealing 2021

Jun 4, 2021

34346_dirs_2021-06-04_344f2f64-6ba1-4fb5-99da-c231b0c8a1a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: NRX Pharmaceuticals, Inc. (BRPA)
CIK: 0001719406
Period of Report: 2021-05-24

Reporting Person: BRAC Lending Group LLC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-24	Common Stock	D	869565	—	Disposed	590435	Direct

Footnotes

F1: Form 4 filed on May 25, 2021, erroneously reported 562,435 shares beneficially owned in Column 5. This amendment is being filed to correct the total shares beneficially owned in Column 5.